These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination. Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575 [TBL] [Abstract][Full Text] [Related]
5. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital. Paoletti G; Racca F; Piona A; Melone G; Merigo M; Puggioni F; Ferri S; Azzolini E; Lagioia M; Lamacchia D; Cataldo G; Cecconi M; Canonica GW; Heffler E World Allergy Organ J; 2021 May; 14(5):100541. PubMed ID: 33850601 [TBL] [Abstract][Full Text] [Related]
6. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 and allergy - what have we learned after two and a half years? Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T Allergol Select; 2023; 7():101-112. PubMed ID: 37056446 [TBL] [Abstract][Full Text] [Related]
8. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract. Gaspar A; Moura AL; Cruz C; Borrego LM Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507 [No Abstract] [Full Text] [Related]
10. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics. Otani IM; Tsao LR; Tang M Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274 [TBL] [Abstract][Full Text] [Related]
11. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517 [TBL] [Abstract][Full Text] [Related]
12. The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey. Montera MC; Giordano A; Asperti C; Aruanno A; Barzaghi CE; Bignardi D; Borrelli P; Bommarito L; Busa M; Calafiore P; Carusi V; Cinquini M; Cortellini G; Cocchi R; D'Auria F; De Caro F; Demonte A; Di Leo E; Di Lizia M; Di Rienzo A; Fumagalli F; Kihlgren P; Lodi Rizzini F; Macchia D; Manzotti G; Marra AM; Mileto P; Mietta S; Montagni M; Nettis E; Nucera E; Peveri S; Pivetta D; Pirisi M; Ramirez GA; Rivolta F; Rizzi A; Savoia A; Pedicini A; Scarpa A; Zambito M; Zisa G; Yacoub MR Eur Ann Allergy Clin Immunol; 2024 Jan; 56(1):17-25. PubMed ID: 36927838 [No Abstract] [Full Text] [Related]
13. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy. Khokhar D; O'Shea KM; Akin C; Baldwin JL; Benjamin MR; Ravikumar R; Hosler M; McMorris MS; Sanders GM; Troost JP; Baptist AP; Oberdoerster DT; Kovalszki A J Allergy Clin Immunol Glob; 2022 Nov; 1(4):209-216. PubMed ID: 36090592 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570 [TBL] [Abstract][Full Text] [Related]
15. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines. Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709 [TBL] [Abstract][Full Text] [Related]
16. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy. Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580 [TBL] [Abstract][Full Text] [Related]
17. Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic. Mortz CG; Kjaer HF; Rasmussen TH; Rasmussen HM; Garvey LH; Bindslev-Jensen C Clin Transl Allergy; 2022 Jan; 12(1):e12111. PubMed ID: 35028130 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis. Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821 [TBL] [Abstract][Full Text] [Related]
19. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521 [TBL] [Abstract][Full Text] [Related]
20. Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines. Cortellini G; Raiteri A; Biagioni B; Liberati S; Lippolis D; Cortellini G; Piscaglia F Eur Ann Allergy Clin Immunol; 2023 Sep; 55(5):229-234. PubMed ID: 36047485 [No Abstract] [Full Text] [Related] [Next] [New Search]